Literature DB >> 28879603

Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.

Eliza W Beal1, Dmitry Tumin2, Ali Kabir1,3, Dimitrios Moris1, Xu-Feng Zhang1,4, Jeffery Chakedis1, Kenneth Washburn5, Sylvester Black5, Carl M Schmidt1, Timothy M Pawlik6.   

Abstract

INTRODUCTION: Increasing incidence of lifelong obesity and associated nonalcoholic steatohepatitis in younger birth cohorts may have contributed to growing incidence of hepatocellular carcinoma (HCC) in the USA. Yet, the contribution of cohort effects to trends in HCC incidence is unclear.
METHODS: Using data from the Surveillance, Epidemiology, and End Results (SEER) program 1973-2013, race- and gender-specific trends in HCC incidence in the USA were decomposed using age-period-cohort (APC) modeling.
RESULTS: Among SEER registry sites included in the analysis, there were 25,532 cases of HCC diagnosed including 15,867 (62%) White males, 3541 (14%) Black males, 5009 (20%) White females, and 1115 (4%) Black females. HCC incidence increases across periods, especially among men. Underlying this increase, APC models found significant cohort effects among White men, White women, and Black men, with rapid growth in HCC risk among cohorts born after 1940. A similar cohort trend among Black women did not reach statistical significance when compared to an age-period model.
CONCLUSIONS: Cohort-specific trends have significantly contributed to increasing HCC incidence in recent decades. The rapid increase in HCC risk among younger cohorts suggests that the incidence of HCC will continue increasing in the near future.

Entities:  

Mesh:

Year:  2018        PMID: 28879603     DOI: 10.1007/s00268-017-4194-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Age-period-cohort models for the Lexis diagram.

Authors:  B Carstensen
Journal:  Stat Med       Date:  2007-07-10       Impact factor: 2.373

Review 2.  Hepatocellular carcinoma--epidemiological trends and risk factors.

Authors:  Kerstin Schütte; Jan Bornschein; Peter Malfertheiner
Journal:  Dig Dis       Date:  2009-06-22       Impact factor: 2.404

3.  Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014.

Authors:  Cynthia L Ogden; Margaret D Carroll; Hannah G Lawman; Cheryl D Fryar; Deanna Kruszon-Moran; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

4.  Emerging trends in hepatocellular carcinoma incidence and mortality.

Authors:  Basile Njei; Yaron Rotman; Ivo Ditah; Joseph K Lim
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

5.  U.S. Burden of Cancer by Race and Ethnicity According to Disability-Adjusted Life Years.

Authors:  Joannie Lortet-Tieulent; Isabelle Soerjomataram; Chun Chieh Lin; Jan Willem W Coebergh; Ahmedin Jemal
Journal:  Am J Prev Med       Date:  2016-11       Impact factor: 5.043

6.  Ledipasvir/Sofosbuvir (harvoni): improving options for hepatitis C virus infection.

Authors:  Diana Gritsenko; Gregory Hughes
Journal:  P T       Date:  2015-04

7.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

8.  Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

Authors:  Sean F Altekruse; S Jane Henley; James E Cucinelli; Katherine A McGlynn
Journal:  Am J Gastroenterol       Date:  2014-02-11       Impact factor: 10.864

9.  An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.

Authors:  Guo Yonghao; Xu Jin; Li Jun; Dong Pumei; Ye Ying; Feng Xiuhong; Zhang Yanyang; Guo Wanshen
Journal:  Int J Infect Dis       Date:  2015-10-09       Impact factor: 3.623

Review 10.  Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.

Authors:  Thomas F Baumert; Frank Jühling; Atsushi Ono; Yujin Hoshida
Journal:  BMC Med       Date:  2017-03-14       Impact factor: 11.150

View more
  4 in total

1.  Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume.

Authors:  Eliza W Beal; Rittal Mehta; Katiuscha Merath; Diamantis I Tsilimigras; J Madison Hyer; Anghela Paredes; Mary E Dillhoff; Jordan Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-05-08       Impact factor: 3.452

Review 2.  Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.

Authors:  Clifford Akateh; Sylvester M Black; Lanla Conteh; Eric D Miller; Anne Noonan; Eric Elliott; Timothy M Pawlik; Allan Tsung; Jordan M Cloyd
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

3.  Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.

Authors:  Nima Fattahi; Negar Rezaei; Mohsen Asadi-Lari; Moein Yousefi; Zahra Madadi; Kimiya Gohari; Ali Sheidaei; Esmaeil Mohammadi; Nazila Rezaei; Mahboubeh Parsaeian; Farzad Kompani; Farshad Farzadfar
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

4.  Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries.

Authors:  Shams Rahman; Deanna Wathington; Tim Waterboer; Michael Pawlita; Luisa L Villa; Eduardo Lazcano-Ponce; Martina Willhauck-Fleckenstein; Nicole Brenner; Anna R Giuliano
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.